• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CG Oncology, Inc. - Common stock (NQ:CGON)

    41.52 +1.35 (+3.36%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 772,236
    Open 40.14
    Bid (Size) 41.56 (100)
    Ask (Size) 43.00 (100)
    Prev. Close 40.17
    Today's Range 39.84 - 41.60
    52wk Range 14.80 - 46.01
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits ↗
    A full exit during a volatile stretch raises a sharper question than timing alone. 
    Via The Motley Fool
    News headline image
    SUO-CTC and CG Oncology Announce the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
    From CG Oncology Inc.
    Via GlobeNewswire

    Performance

    YTD
    +43.3%
    +43.3%
    1 Month
    -4.0%
    -4.0%
    3 Month
    +3.1%
    +3.1%
    6 Month
    +57.6%
    +57.6%
    1 Year
    +45.7%
    +45.7%

    More News

    Read More
    News headline image
    New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    Up 44% Since IPO: Why a Major Fund Just Made a $45 Million Bet on This Digital Health Stock ↗
    Via The Motley Fool
    Topics Initial Public Offering Regulatory Compliance
    News headline image
    Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound? ↗
    Via The Motley Fool
    News headline image
    Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    CG Oncology Announces New Board Member and Board Transition
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover ↗
    Via The Motley Fool
    News headline image
    CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    Why Cg Oncology Stock Rocketed 7% Higher Today ↗
    Via The Motley Fool
    News headline image
    CG Oncology Stock Signals Bullish Momentum Ahead ↗
    Via Benzinga
    News headline image
    CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    CG Oncology Completes Enrollment in PIVOT-006
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    CG Oncology’s Executive Leadership to Participate in Upcoming Investor Conferences
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    Cg Oncology (CGON) Q2 Loss Widens 93% ↗
    Via The Motley Fool
    News headline image
    CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    Which stocks are moving before the opening bell on Tuesday? ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Beyond The Numbers: 7 Analysts Discuss CG Oncology Stock ↗
    Via Benzinga
    Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
    Via Investor Brand Network

    Frequently Asked Questions

    Is CG Oncology, Inc. - Common stock publicly traded?
    Yes, CG Oncology, Inc. - Common stock is publicly traded.
    What exchange does CG Oncology, Inc. - Common stock trade on?
    CG Oncology, Inc. - Common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for CG Oncology, Inc. - Common stock?
    The ticker symbol for CG Oncology, Inc. - Common stock is CGON on the Nasdaq Stock Market
    What is the current price of CG Oncology, Inc. - Common stock?
    The current price of CG Oncology, Inc. - Common stock is 41.52
    When was CG Oncology, Inc. - Common stock last traded?
    The last trade of CG Oncology, Inc. - Common stock was at 12/31/25 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.